Hamburg University Medical Centre Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20251, Germany
NCT Number: NCT04978870
This study aims to
1. determine sensitivity and specificity of the Confusion Assessment Method for Postanesthesia Care Unit (CAM-PACU) 2. examine the effect of postanesthesia care unit delirium (PACU delirium) on the emergence of later onset postoperative delirium (POD) as well as cognitive recovery until one month postoperatively
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Hamburg, Free and Hanseatic City of Hamburg, 20251, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15-240 minutes postoperatively
in reference to International Classification of Diseases-Version 10 (ICD-10)
Time frame: 0-5 days postoperatively
3D CAM and/or medical record
Time frame: 15-240 minutes postoperatively
CAM-PACU
Time frame: before, 7 and 30 days postoperatively
Montreal Cognitive Assessment (MoCA, 0-30 points, higher score = better outcome), Cognitive Telephone Screening Instrument (COGTEL), Patient Reported Outcomes Measurement Information System (PROMIS Neuro QoL)
Time frame: 30 days postoperatively
European Perioperative Clinical Outcome (EPCO) definitions; Standardised Endpoints in Perioperative Medicine - Core Outcome Measures in Perioperative and Anaesthetic Care (Step-COMPAC) definitions
Time frame: before, 3 and 12 months after implementation of CAM-PACU
self-designed questionnaire
Universitätsklinikum Hamburg-Eppendorf
Other
Diagnosis, Incidence and Consequences of Postoperative Delirium in Elderly Patients in the Post-anaesthetic Care Unit
Acronym: PADE-DIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06630390
Alzheimer Disease, Brain Diseases
Rochester, New York, United States
View Trial DetailsNCT03802396
Cognition Disorders, Cognitive Dysfunction
Durham, North Carolina, United States
View Trial DetailsNCT06567574
Cognition Disorders, Cognitive Dysfunction
Palo Alto, California, United States
View Trial DetailsNCT04214496
Cognition Disorders, Cognitive Dysfunction
Santiago, Chile
View Trial Details